Childhood Cancer Research

Share

Too many types of childhood cancer still have no known cure or treatment. In 2018, more than 15,000 children under age 19 will be diagnosed with cancer. 

We must ensure that researchers have the essential tools to fight childhood cancer and make sure children with cancer not only survive, but thrive. 

 

Over 15,000 U.S. children under age 19 will be diagnosed with cancer in 2018.

Take Action

children celebrating

Congress: Fund The STAR Act To Help Prevent And Treat Childhood Cancer

Ask your member of Congress to ensure the STAR Act is fully funded so vital work on childhood cancer research, surveillance, and survivorship can continue. 

Latest Updates

Cancer Candor Blog
March 28, 2019

Mariah Forster Olson, an ACS CAN Ambassador Constituent Team Lead (ACT Lead), traveled to Washington, D.C. this week to share her story as a childhood cancer survivor and to advocate on behalf of other patients and survivors during the 2019 Childhood Cancer Action Days.

March 27, 2019
National

Washington, D.C. – Advocates from the American Cancer Society Cancer Action Network (ACS CAN) joined more than 200 other childhood cancer patients, survivors, caretakers and family members on Capitol Hill today for the Alliance for Childhood Cancer’s eighth annual Childhood Cancer Action Day. This year, participants will ask their congressional

March 26, 2019
New Mexico

SANTA FE, N.M. -- Santa Fe residents and American Cancer Society Cancer Action Network (ACS CAN) volunteers Dr. Janis Gonzales and Liesl Gonzales travel to Washington, D.C., today to share the story of their daughter and sister, urge lawmakers to fully fund the bipartisan Childhood Cancer Survivorship, Treatment, Access and

March 26, 2019
Missouri

St. Louis native and American Cancer Society Cancer Action Network volunteer Melissa Horn will travel to the U.S. Capitol today to talk about her cancer experience and to urge lawmakers to ensure childhood cancer research remains a national priority.

Childhood Cancer Research Resources

ACS CAN’s official endorsement of the RACE for Children Act, a bill that will encourage new research and development in childhood cancer.

This report examines the drug development landscape for childhood cancer, identifying scientific, logistical, economic and ethical challenges that are unique to pediatric cancer drug development.